Matches 1 - 50 out of 409 1 2 3 4 5 6 7 8 9 >


Match Document Document Title
US20120321612 SYSTEMS AND METHODS FOR TREATING POST-OPERATIVE, ACUTE, AND CHRONIC PAIN USING AN INTRA-MUSCULAR CATHETER ADMINISTRATED COMBINATION OF A LOCAL ANESTHETIC AND A NEUROTOXIN PROTEIN  
Systems, and methods for the use of such systems, are described that allow for the administration of a combination of a sustained release local anesthetic compound (such as bupivicaine) through a...
US20140140983 METHOD FOR TREATMENT OF AUTONOMIC NERVOUS SYSTEM DISORDERS  
Botulinum toxin, among other presynaptic neurotoxins is used for the treatment of autonomic nervous system disorders such as irritable bowel syndrome. The neurotoxin is delivered to target the...
US20120093920 METHOD OF TREATMENT FOR BLADDER DYSFUNCTION  
Liposomes are used for intravesical drug delivery, especially delivery of botulinum toxin (BoNT) to help improve lower urinary tract symptoms by decreasing bladder irritation and frequency. The...
US20130236446 TREATMENT OF MIGRAINE HEADACHE WITH DIFFUSION OF TOXIN IN NON-MUSCLE RELATED AREAS OF THE MOUTH  
A method for treating a patient with migraine headache includes administering to the patient a therapeutically effective amount of an invertebrate presynaptic neurotoxin in a pharmaceutically safe...
US20140079687 Suture line Administration Technique using Botulinum Toxins  
The present invention utilizes patient-specific landmarks in order to treat headache pain. In one aspect, the present invention relates to the administration of Clostridial toxins, such as a...
US20150216953 BOTULINUM TOXIN THERAPY FOR SKIN DISORDERS  
Methods for treating skin disorders by local administration of a Clostridial toxin, such as a botulinum toxin, to a patient with a skin disorder.
US20150010533 BOTULINUM TOXIN THERAPY FOR SKIN DISORDERS  
Methods for treating skin disorders by local administration of a Clostridial toxin, such as a botulinum toxin, to a patient with a skin disorder.
US20140030248 INJECTION PARADIGM FOR ADMINISTRATION OF BOTULINUM TOXINS  
Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional...
US20130330321 INJECTION PARADIGM FOR ADMINISTRATION OF BOTULINUM TOXINS  
Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional...
US20130224180 INJECTION PARADIGM FOR ADMINISTRATION OF BOTULINUM TOXINS  
Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional...
US20150030584 TRANSPORT PROTEIN WHICH IS USED TO INTRODUCE CHEMICAL COMPOUNDS INTO NERVE CELLS  
The invention relates to a transport protein which can be obtained by modifying the heavy chain of the neurotoxin formed by Clostridium botulinum. The protein binds specifically to nerve cells...
US20150071879 Stabilization of Aqueous Compositions of Proteins with Displacement Buffers  
An aqueous composition having increased protein stability is obtained by: a. determining a pH at which the protein has stability at the desired temperature; b. adding to the composition at least...
US20150064167 METHOD FOR TREATING PREMATURE EJACULATION WITH A BOTULINUM NEUROTOXIN  
Methods for prolongation of climax time in a patient in need thereof are presented, as are methods for treating premature ejaculation by local administration of a Clostridial neurotoxin, such a...
US20140140981 METHOD FOR TREATING PREMATURE EJACULATION WITH A BOTULINUM NEUROTOXIN  
Methods for prolongation of climax time in a patient in need thereof are presented, as are methods for treating premature ejaculation by local administration of a Clostridial neurotoxin, such a...
US20120148563 Method for Treating Premature Ejaculation with a Botulinum Neurotoxin  
Methods for prolongation of climax time in a patient in need thereof are presented, as are methods for treating premature ejaculation by local administration of a Clostridial neurotoxin, such a...
US20140065130 METHOD FOR TREATING PREMATURE EJACULATION WITH A NEUROTOXIN  
Methods for treating premature ejaculation and prolongation of climax time in a patient in need thereof by local administration of a Clostridial neurotoxin, such as a botulinum toxin, are provided.
US20110135704 Infection Control for Surgical and Trauma Patients  
Apparatus and methods for disrupting the colonization of Staphylococcus aureus are disclosed. A lysostaphin antimicrobial coating for bone implants and a lysostaphin gel for use on open wounds to...
US20140294803 METHODS FOR TREATING HEADACHE  
A headache can be treated more effectively by co-administration of a botulinum toxin and a triptan drug to a patient and/or the effectiveness of a triptan medication can be increased. The...
US20140142718 FLEXIBLE TISSUE MATRIX AND METHODS FOR JOINT REPAIR  
A synthetic, flexible tissue matrix and methods for repairing hyaline cartilage defects in a joint using the flexible tissue matrix are described. The flexible tissue matrix includes a high...
US20140328892 USE OF ALFIMEPRASE IN THE TREATMENT OF THROMBOSIS  
Methods for treatment of arterial or venous thrombosis in patients undergoing an endovascular intervention or a surgical procedure, and more particularly, administering alfimeprase directly into...
US20150174216 Methods for Treating Adhesive Capsulitis  
The invention relates to the discovery that collagenase injections are effective in lyse the collagenous adhesions in the shoulder and treat the disorder, adhesive capsulitis. As such, the...
US20130330320 Methods for Treating Adhesive Capsulitis  
The invention relates to the discovery that collagenase injections are effective in lyse the collagenous adhesions in the shoulder and treat the disorder, adhesive capsulitis. As such, the...
US20140335072 Method of Treating or Reducing EFP  
The present invention is directed to a method of treating or reducing EFP in a patient comprising administering one or multiple low dose injections of collagenase to an area affected by EFP. The...
US20120282241 Method of Treating Persistent Genital Arousal Disorder with a Neurotoxin  
A method of controlling dysregulation of the dorsal cutaneous nerve of the clitoris and, in particular, a method for treating PGAD is provided. In one aspect, the method comprises administering a...
US20150079069 METHODS FOR MODIFICATION OF TISSUES  
Methods for modification of mechanical properties or a shape of a mammalian tissue, excluding scar, blood clot, fat; including a step of contacting the tissue with an isolated eukaryotic...
US20140170132 PROPHYLATIC TREATMENT OF HERPES RECURRENCE  
The present invention relates to methods for prophylactic treatment of Herpes recurrence with a Clostridial neurotoxin, such as a botulinum neurotoxin or variant thereof.
US20140322197 METHODS FOR TREATMENT OF HIP AND GROIN PAIN ASSOCIATED WITH FEMOROACETABULAR IMPINGEMENT (FAI)  
Methods for treating or alleviating symptoms associated with femoroacetabular impingement (FAI) by local administration of a clostridial derivative, such as a botulinum toxin, to the hip capsule...
US20140193394 TREATMENT OF CARPAL TUNNEL SYNDROME BY INJECTION OF THE FLEXOR RETINACULUM  
An apparatus and method for identifying the flexor retinaculum of the carpal tunnel, injecting an effective amount of an agent into at least a portion of flexor retinaculum or tissue adjacent...
US20140248258 METHODS FOR IMPROVING GUT HEALTH  
The present invention provides methods for improving gut health. In particular, the invention provides methods for improving gut health by improving the digestibility of dietary proteins,...
US20120225050 METHODS FOR IMPROVING GUT HEALTH  
The present invention provides methods for improving gut health. In particular, the invention provides methods for improving gut health by improving the digestibility of dietary proteins,...
US20150165003 LONG LASTING EFFECT OF NEW BOTULINUM TOXIN FORMULATIONS  
The invention relates to the use of an animal-protein-free botulinum toxin composition to treat a disease, disorder or condition in a patient in need thereof whereby the animal-protein-free...
US20130195838 Methods of Treating Cancer Using Growth Factor Retargeted Endopeptidases  
The present specification discloses TVEMPs, compositions comprising such TVEMPs and methods of treating cancer in a mammal using such TVEMP compositions.
US20100310544 COMPOSITION COMPRISING CALCIUM IONS AND AT LEAST ONE PROTEOLYTIC ENZYME FOR USE IN THE IN VITRO AND IN VIVO REGENERATION OF CUTANEOUS AND CONNECTIVE TISSUES  
The invention is based on the finding that calcium ions and proteolytic enzymes, particularly papain, act in a synergetic way in the regeneration of skin and connective tissues. Thus, such a...
US20110044960 MEDICAMENT, DENTAL MATERIAL, AND METHOD OF SCREENING  
The present invention provides a novel and creative dental materials for treatment of pulpitis and/or enhancement of dentinogenesis. The dental materials of the present invention contain at least...
US20110081320 Treatment/Cure of Autoimmune Disease  
An embodiment entails administering an effective amount of a product such as a protease or a source of a protease that destroys or deactivates an immunogen, mimic or antigen specific to a...
US20150093373 TREATMENT OF PULMONARY VASCULAR REMODELING WITH NEPRILYSIN  
The present invention relates to agonists of Neprilysin and their use in preventing and treating pulmonary vascular remodeling. Also described are diagnostic and screening applications stemming...
US20120121573 Treatment of Pulmonary Vascular Remodeling With Neprilysin  
The present invention relates to agonists of Neprilysin and their use in preventing and treating pulmonary vascular remodeling. Also described are diagnostic and screening applications stemming...
US20140271611 SUBCUTANEOUS ADMINISTRATION OF ADAMTS13  
This invention relates to methods of subcutaneous administration of ADAMTS13 formulations to a treat a disease or condition associated with ADAMTS13 and VWF dysfunction. Furthermore, evidence of...
US20120195878 PROTOCOL FOR THE ADMINISTRATION OF BOTULINUM TOXINS  
Embodiments of the invention provide treatment methods utilizing botulinum toxins. Certain methods describe specific time intervals between administration sessions. Administration sessions can...
US20110256095 Tissue Matrix System  
The present application discloses matrix compositions to support the repair of tissue defects such as an injury to tendon tissue, ligament tissue, vascular tissue, dermal tissue, or muscle tissue....
US20140178357 STABILIZED LIQUID AND LYOPHILIZED ADAMTS13 FORMULATIONS  
The present invention relates to formulations of ADAMTS13 with enhanced or desirable properties. As such, the invention provides liquid and lyophilized formulations of ADAMTS13 that are suitable...
US20110229455 STABILIZED LIQUID AND LYOPHILIZED ADAMTS13 FORMULATIONS  
The present invention relates to formulations of ADAMTS13 with enhanced or desirable properties. As such, the invention provides liquid and lyophilized formulations of ADAMTS13 that are suitable...
US20140170106 METHODS AND COMPOSITIONS SUITABLE FOR IMPROVED REATTACHMENT OF DETACHED CARTILAGE TO SUBCHONDRAL BONE  
The methods and compositions disclosed herein are effective in the promoting the reattachment of delaminated cartilage to bone. The methods (and related compositions) comprise the removal of the...
US20120189677 FORMULATIONS  
A formulation comprising botulinum toxin (BT), lipid and surfactant, characterised in that the lipid and surfactant are in the form of macromolecular assemblies of less than 100 nm in diameter....
US20140154237 METHODS AND KITS FOR TOPICAL APPLICATION, REMOVAL, AND INACTIVATION OF THERAPEUTIC OR COSMETIC TOXIN COMPOSITIONS  
This invention relates to methods and kits for safely removing and inactivating topical therapeutic or cosmetic compositions. The methods and kits according to the invention are particularly well...
US20120294844 Methods And Kits For Topical Application, Removal, And Inactivation Of Therapeutic Or Cosmetic Toxin Compositions  
This invention relates to methods and kits for safely removing and inactivating topical therapeutic or cosmetic compositions. The methods and kits according to the invention are particularly well...
US20120282242 COMPOSITIONS, TARGETS, METHODS AND DEVICES FOR THE THERAPY OF OCULAR AND PERIOCULAR DISORDERS  
Methods for treating ocular and periocular disorders by administration to a human patient of a therapeutically effective amount of a compound that modulates muscle action.
US20110091421 Methods of Novel Therapeutic Candidate Identification Through Gene Expression Analysis in Vascular-Related Diseases  
The present invention discloses multiple treatment regimens for vascular-related diseases and disorders. The present invention provides for methods of treating vascular-related disorders based on...
US20140199288 PHARMACEUTICAL COMPOSITIONS CONTAINING BOTULINUM NEUROTOXIN  
This invention relates to the use of a composition comprising a polysaccharide and a botulinum toxin for reducing a skin wrinkle. In some embodiments, the polysaccharide comprises disaccharides....
US20140212405 Fibrinolytic/Proteolytic Treatment of Myofacial and Neuropathic Pain and Related Conditions  
A method is disclosed to dissolve protein deposited in muscle. The method includes the step of administering an effective amount of an agent selected from the group consisting of fibrinolytics,...

Matches 1 - 50 out of 409 1 2 3 4 5 6 7 8 9 >